More search options
Basket icon
No items
Basket icon

Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Case
-
Reference no. 9A99N032
Subject category: Finance, Accounting and Control
Authors: Robert W White (Ivey Business School, Western University); Darryl Green (Ivey Business School, Western University); Branko Djordjevic (Ivey Publishing, Western University)
Published by: Ivey Publishing
Originally published in: 1998
Version: 1999-11-25
Length: 20 pages
Data source: Field research
Topics: Acquisitions; Bidding; Emerging markets
Share a link: https://casecent.re/p/15271
| No reviews for this item
This product has not been used yet
View our pricing guide or login to see prices.

Abstract

ICN Pharmaceuticals Inc had submitted a bid to purchase Polfa Rzeszow, the Polish state-owned pharmaceutical corporation. Three major pharmaceutical companies (Merck & Co, Inc, Hoechst Marion Roussel and ICN) were involved in the final round of bidding. ICN''s bid was low by comparison. Under pressure from management, the Polish government asked ICN to resubmit its bid to make it more competitive with the other bids. Given the opportunity to rebid for Polfa, ICN was faced with deciding how much ICN should offer for the company and on what terms.
Location:
USA, Poland
Industry:
Chemicals and allied products
Size:
Large
Other setting(s):
1997
Teaching note software
-
Reference no. 8A99N32
Subject category: Finance, Accounting and Control
Authors: Robert W White (Ivey Business School, Western University); Darryl Green (Ivey Business School, Western University); Branko Djordjevic (Ivey Publishing, Western University)
Published by: Ivey Publishing
Published in: 1998
Format: .ppt
Data source: Field research
View full details

About

Abstract

ICN Pharmaceuticals Inc had submitted a bid to purchase Polfa Rzeszow, the Polish state-owned pharmaceutical corporation. Three major pharmaceutical companies (Merck & Co, Inc, Hoechst Marion Roussel and ICN) were involved in the final round of bidding. ICN''s bid was low by comparison. Under pressure from management, the Polish government asked ICN to resubmit its bid to make it more competitive with the other bids. Given the opportunity to rebid for Polfa, ICN was faced with deciding how much ICN should offer for the company and on what terms.

Settings

Location:
USA, Poland
Industry:
Chemicals and allied products
Size:
Large
Other setting(s):
1997

Related

Teaching note software
-
Reference no. 8A99N32
Subject category: Finance, Accounting and Control
Authors: Robert W White (Ivey Business School, Western University); Darryl Green (Ivey Business School, Western University); Branko Djordjevic (Ivey Publishing, Western University)
Published by: Ivey Publishing
Published in: 1998
Format: .ppt
Data source: Field research
View full details